191
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Case Report: A Rare Case of Hepatoid Adenocarcinoma in Stomach and Duodenum Simultaneously

, , , , &
Pages 2185-2191 | Published online: 13 Jul 2022

References

  • Akiyama S, Tamura G, Endoh Y, et al. Histogenesis of hepatoid adenocarcinoma of the stomach: molecular evidence of identical origin with coexistent tubular adenocarcinoma. Int J Cancer. 2003;106:510–515. doi:10.1002/ijc.11246
  • Gao HY, Zhang YP, Yan YW, Shen HF. A case report of hepatoid adenocarcinoma of the stomach with liver and spleen metastasis misdiagnosed as advanced liver cancer. Zhonghua Gan Zang Bing Za Zhi. 2019;27:719–720. Chinese. doi:10.3760/cma.j.issn.1007-3418.2019.09.013
  • Nagai Y, Kato T, Harano M, et al. A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy. Gan to Kagaku Ryoho. 2014;41:2349–2351. Japanese.
  • Ogbonna OH, Sakruti S, Sulieman M, Ali A, Shokrani B, Oneal P. Hepatoid adenocarcinoma of the duodenum: an unusual location. Case Rep Oncol. 2016;9:182–187. doi:10.1159/000444746
  • Zeng XY, Yin YP, Xiao H, et al. Clinicopathological characteristics and prognosis of hepatoid adenocarcinoma of the stomach: evaluation of a pooled case series. Curr Med Sci. 2018;38:1054–1061. doi:10.1007/s11596-018-1983-1
  • Ogiwara S, Furihata M, Fukami K, Yamashita A, Yao T, Osada T. Hepatoid adenocarcinoma with enteroblastic differentiation in the sigmoid colon: lessons from a rare case. Am J Gastroenterol. 2019;114:684–685. doi:10.14309/ajg.0000000000000176
  • Zou M, Li Y, Dai Y, et al. AFP-producing hepatoid adenocarcinoma (HAC) of peritoneum and omentum: a case report and literature review. Onco Targets Ther. 2019;12:7649–7654. doi:10.2147/OTT.S216501
  • Williams NL, Palmer JD, Bar-Ad V, et al. Hepatoid carcinoma of the pancreas: a case report and review of the literature. Case Rep Pancreat Cancer. 2015;1:3–6. doi:10.1089/crpc.2015.29001.nlw
  • Choi WK, Cho DH, Yim CY, Lee NR. Primary hepatoid carcinoma of the ovary: a case report and review of the literature. Medicine. 2020;99:e20051. doi:10.1097/MD.0000000000020051
  • Xia R, Zhou Y, Wang Y, Yuan J, Ma X. Hepatoid adenocarcinoma of the stomach: current perspectives and new developments. Front Oncol. 2021;11:633916. doi:10.3389/fonc.2021.633916
  • Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303–310. doi:10.1097/00000478-200303000-00003
  • Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. doi:10.1038/nprot.2008.211
  • Aster JC, Pear WS, Blacklow SC. The varied roles of notch in cancer. Annu Rev Pathol. 2017;12:245–275. doi:10.1146/annurev-pathol-052016-100127
  • Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med. 1970;78:1277–1278. Danish.
  • Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y, Aizawa M. An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report. Cancer. 1985;56:840–848. doi:10.1002/1097-0142(19850815)56:4<840::AID-CNCR2820560423>3.0.CO;2-E
  • Su JS, Chen YT, Wang RC, Wu CY, Lee SW, Lee TY. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol. 2013;19:321–327. doi:10.3748/wjg.v19.i3.321
  • Simmet V, Noblecourt M, Lizee T, et al. Chemotherapy of metastatic hepatoid adenocarcinoma: literature review and two case reports with cisplatin etoposide. Oncol Lett. 2018;15:48–54. doi:10.3892/ol.2017.7263
  • Soreide JA. Therapeutic approaches to gastric hepatoid adenocarcinoma: current perspectives. Ther Clin Risk Manag. 2019;15:1469–1477. doi:10.2147/TCRM.S204303